[
    [
        {
            "time": "",
            "original_text": "领先大市-B评级 医药行业2017年业绩前瞻：整体增长稳健 重点把握业绩优质龙头股",
            "features": {
                "keywords": [
                    "医药行业",
                    "2017年业绩",
                    "整体增长稳健",
                    "业绩优质",
                    "龙头股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "领先大市-B评级 医药行业2017年业绩前瞻：整体增长稳健 重点把握业绩优质龙头股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药行业业绩冰火两重天 辅助用药使用受限致多家药企业绩下滑",
            "features": {
                "keywords": [
                    "医药行业",
                    "业绩下滑",
                    "辅助用药",
                    "使用受限"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业业绩冰火两重天 辅助用药使用受限致多家药企业绩下滑",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]